Marucci, Marena A., Doreen W. Lechner, and Barbara A. Tafuto. “Safety Outcomes of Low Versus High Dose Imatinib Mesylate in Patients With Advanced, Metastatic, or Nonresectable Gastrointestinal Stromal Tumors: A Systematic Review”. Gastrointestinal Tract 2, no. 1 (March 12, 2024). Accessed May 17, 2024. https://www.hksmp.com/journals/git/article/view/482.